Company News

Cambridge, UK, 6th December 2017 / Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce that Chris Brown has been appointed Chief Financial Officer with immediate effect.
Domainex, a drug discovery services company, is pleased to announce that Dr Timo Veromaa has been appointed Executive Chairman with immediate effect.
Domainex launched its fragment screening service, FragmentBuilder, and is the first CRO in the UK to offer MicroScale Thermophoresis (MST) as part of drug discovery services.
Sir Simon Campbell opened the Domainex Medicines Research Centre, which will double the laboratory space available to the company’s growing team of scientists.
11th November 2016
Domainex will hold an opening ceremony on 11th November to mark their relocation to Chesterford Research Park.
To support the company’s growth in drug research services, Domainex is moving to the Churchill Building of Chesterford Research Park.
Latest winner of Domainex Discovery STAR Award is Dr Aude Echalier, Lecturer in Structural Biology of Cancer Related Targets at the University of Leicester.
Domainex Ltd. and Cresset Discovery Services, today announced an alliance to provide their customers with world-class laboratory-based and computational drug discovery services through a seamless combination of their respective capabilities in chemistry and biology.
A new £3.4 million programme will develop new tools to understand which interactions between proteins in the human body are relevant to disease.

Pages